Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants

被引：1
|
作者：
Gokarn, Anant [1 ,2 ]
Shenoy, Ramnath [1 ]
Punatar, Sachin [1 ,2 ]
Mirgh, Sumeet [1 ,2 ]
Chichra, Akanksha [1 ,2 ]
Nayak, Lingaraj [1 ,2 ]
Bonda, Avinash [1 ,2 ]
Jindal, Nishant [1 ,2 ]
Saroha, Megha [1 ]
Toshniwal, Anup [1 ]
Prayag, Parikshit [3 ]
Tripathi, Rachana [4 ]
Kumar, Shesheer [4 ]
Bhat, Vivek [2 ,5 ]
Biswas, Sanjay [2 ,5 ]
Khattry, Navin [1 ,2 ]
机构：
[1] Tata Mem Hosp, Dept Med Oncol, Mumbai, India
[2] Homi Bhabha Natl Inst, Mumbai, India
[3] Deenanath Mangeshkar Hosp, Res Ctr, Infect Dis, Pune, India
[4] Huwel Lifesci Pvt Ltd, Hyderabad, India
[5] Tata Mem Hosp, Dept MicroBiol, Mumbai, India
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 02期
关键词：
REPLICATION;
D O I：
10.1038/s41409-022-01850-z
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：209 / 211
页数：3
相关论文
共 50 条
  • [1] Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants
    Anant Gokarn
    Ramnath Shenoy
    Sachin Punatar
    Sumeet Mirgh
    Akanksha Chichra
    Lingaraj Nayak
    Avinash Bonda
    Nishant Jindal
    Megha Saroha
    Anup Toshniwal
    Parikshit Prayag
    Rachana Tripathi
    Shesheer Kumar
    Vivek Bhat
    Sanjay Biswas
    Navin Khattry
    Bone Marrow Transplantation, 2023, 58 : 209 - 211
  • [2] Efficacy of Artesunate for Treatment of Cytomegalovirus Reactivations in Allogeneic Haematopoietic Stem Cell Transplant Recipients Who Are Intolerant/Unsuitable for Ganciclovir Therapy
    Shenoy, Ramnath K.
    Gokarn, Anant
    Toshniwal, Anup
    Kalantri, Siddhesh Arun
    Chichra, Akanksha
    Punatar, Sachin
    Bonda, Avinash
    Nayak, Lingaraj
    Mathew, Libin J.
    Bhat, Vivek
    Biswas, Sanjay
    Kelkar, Rohini
    Khattry, Navin
    BLOOD, 2019, 134
  • [3] Risk factors of CMV reactivation post allogeneic haematopoietic stem cell transplantation
    Jaskula, E.
    Drabczak-Skrzypek, D.
    Mlynarczewska, A.
    Sedzimirska, M.
    Bogunia-Kubik, K.
    Lange, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S267 - S267
  • [4] A Study to Validate the Rationale and Efficacy of a Pre-emptive approach to the management of Cytomegalovirus (CMV) reactivation post allogeneic haematopoietic stem cell transplantation (HSCT)
    Farah, N.
    Szydlo, R.
    Mitul, P.
    Sridharan, M.
    Sawhney, H.
    Lasa, M.
    Mccue, J.
    Atkins, M.
    Kanfer, E.
    MacDonald, D.
    Milojkovic, D.
    Pavlu, J.
    Olavarria, E.
    Rahemtulla, A.
    Chaidos, A.
    Gabriel, I.
    Apperley, J.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S409 - S410
  • [5] Treatment of cytomegalovirus infection with oral valganciclovir in allogeneic haematopoietic stem cell transplantation
    Uresandi, A
    Bermudez, A
    Yañez, L
    Gonzalez-Mesones, B
    Puente, M
    Baro, J
    Conde, E
    Iriondo, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S187 - S187
  • [6] Epidemiology of cytomegalovirus in allogeneic haematopoietic stem cell transplant recipients
    Moya, R
    Espigado, I
    De la cámara, R
    Rovira, M
    Jarque, I
    Julia, A
    Valera, B
    Herreros, JMC
    BONE MARROW TRANSPLANTATION, 2006, 37 : S183 - S183
  • [7] Foscarnet or acyclovir as prophylaxis for cytomegalovirus reactivation and disease in allogeneic haematopoietic stem cell transplantation from alternative donors
    Pinazzi, M. B.
    Carnevalli, E. C.
    Severino, A.
    Bernasconi, S.
    Majolino, I.
    Locasciulli, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S288 - S288
  • [8] Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplants
    Meijer, E
    Boland, GJ
    Verdonck, LF
    CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (04) : 647 - +
  • [9] Risk of cytomegalovirus infection in paediatric allogeneic stem cell transplants
    Haastrup, E
    Müller, K
    Jacobsen, N
    Lauersen, HB
    Heilmann, C
    BONE MARROW TRANSPLANTATION, 2001, 27 : S156 - S156
  • [10] The applicability of cellular immunotherapy to cytomegalovirus (CMV): A retrospective study of allogeneic stem cell transplants (SCT) and CMV reactivation
    Diamanti, P.
    Garland, R. J.
    Groves, S. J.
    Nolan, R.
    Carrington, D.
    Marks, D. I.
    Robinson, S. P.
    Goulden, N. J.
    Cornish, J. M.
    Pamphilon, D. H.
    Blair, A.
    Steward, C. G.
    CYTOTHERAPY, 2006, 8
12345